PCMC
CALT

Planning Capital Management Corporation’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Planning Capital Management Corporation’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-877
Closed -$34.2K – 921
2024
Q2 		$34.2K Hold
877
– – 0.02% 225
2024
Q1 		$18.4K Hold
877
– – 0.01% 305
2023
Q4 		$22.6K Buy
+877
New +$16.4K 0.02% 272

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Planning Capital Management Corporation's CALT Position: Q3 2024 in Review

Planning Capital Management Corporation sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 877 shares — an estimated $34.2K sold.

Planning Capital Management Corporation first reported a position in CALT in Q4 2023 and held it in 3 quarters. The position peaked at $34.2K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Planning Capital Management Corporation reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Planning Capital Management Corporation sold 877 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $34.2K.
  • Planning Capital Management Corporation first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2023 and held it in 3 quarters.
  • Planning Capital Management Corporation's Calliditas Therapeutics AB American Depositary Shares position peaked at $34.2K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.